Spruce Biosciences's three largest insider shareholders as of September 29, 2026 are Holdings A/S Novo (TenPercentOwner, 33.99K shares), Javier B. Szwarcberg (Chief Executive Officer, 19.27K shares), Samir M. Gharib (President And Cfo, 8.26K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Holdings A/S Novo | TenPercentOwner | 33,992 | 0 | 33,992 | 51.5% | 25 Mar, 2024 |
| 2 | Javier B. Szwarcberg | Chief Executive Officer | 19,270 | 0 | 19,270 | 29.2% | 09 Jul, 2026 |
| 3 | Samir M. Gharib | President And Cfo | 8,263 | 0 | 8,263 | 12.5% | 17 Dec, 2025 |
| 4 | Ralph William Iii Charlton | Chief Medical Officer | 2,151 | 0 | 2,151 | 3.3% | 20 Dec, 2024 |
| 5 | Douglas Kirk Ways | Interim Chief Medical Officer | 1,250 | 0 | 1,250 | 1.9% | 21 Jan, 2026 |
| 6 | Healthcare Partners Llc Parkman | TenPercentOwner | 0 | 1,050 | 1,050 | 1.6% | 15 Oct, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 27 Jul, 2026 | Adrian W Quartel | Chief Medical Officer | Acquired A | 13,000 | $0.00 | $0 | 13,000 | Direct |
| 30 Jun, 2026 | Javier B. Szwarcberg | Chief Executive Officer | Acquired A | 266 | $4.53 | $1.21K | 19,270 | Direct |
| 21 May, 2026 | Percival Barretto-Ko | Director | Acquired A | 1,700 | $0.00 | $0 | 1,700 | Direct |
| 21 May, 2026 | Camilla V Simpson | Director | Acquired A | 1,700 | $0.00 | $0 | 1,700 | Direct |
| 21 May, 2026 | Michael G Grey | Executive Chairman | Acquired A | 1,700 | $0.00 | $0 | 1,700 | Direct |
| 21 May, 2026 | Keli Walbert | Director | Acquired A | 1,700 | $0.00 | $0 | 1,700 | Direct |
| 21 May, 2026 | Daniel K Spiegelman | Director | Acquired A | 1,700 | $0.00 | $0 | 1,700 | Direct |
| 09 Mar, 2026 | Corwin Dale Hooks | Chief Commercial Officer | Acquired A | 11,000 | $0.00 | $0 | 11,000 | Direct |
| 11 Dec, 2025 | Douglas Kirk Ways | Interim Chief Medical Officer | Acquired M | 1,250 | $0.00 | $0 | 1,250 | Direct |
| 11 Dec, 2025 | Douglas Kirk Ways | Interim Chief Medical Officer | Acquired A | 5,000 | $0.00 | $0 | 5,000 | Direct |
| 11 Dec, 2025 | Douglas Kirk Ways | Interim Chief Medical Officer | Disposed M | 1,250 | $0.00 | $0 | 3,750 | Direct |
| 11 Dec, 2025 | Douglas Kirk Ways | Interim Chief Medical Officer | Acquired A | 266 | — | — | 266 | Direct |
| 11 Dec, 2025 | Douglas Kirk Ways | Interim Chief Medical Officer | Disposed D | 266 | — | — | 0 | Direct |
| 11 Dec, 2025 | Douglas Kirk Ways | Interim Chief Medical Officer | Acquired A | 400 | — | — | 400 | Direct |
| 11 Dec, 2025 | Douglas Kirk Ways | Interim Chief Medical Officer | Disposed D | 400 | — | — | 0 | Direct |
| 31 Dec, 2025 | Javier B. Szwarcberg | Chief Executive Officer | Acquired A | 4,690 | $4.53 | $21.25K | 19,004 | Direct |
| 15 Dec, 2025 | Samir M. Gharib | President And Cfo | Acquired M | 496 | $0.00 | $0 | 8,112 | Direct |
| 15 Dec, 2025 | Javier B. Szwarcberg | Chief Executive Officer | Acquired M | 1,480 | $0.00 | $0 | 14,478 | Direct |
| 15 Dec, 2025 | Samir M. Gharib | President And Cfo | Disposed F | 178 | $80.67 | $14.36K | 7,934 | Direct |
| 15 Dec, 2025 | Javier B. Szwarcberg | Chief Executive Officer | Disposed F | 752 | $80.67 | $60.66K | 13,726 | Direct |